1. Home
  2. DNUT vs GOSS Comparison

DNUT vs GOSS Comparison

Compare DNUT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.13

Market Cap

541.3M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.45

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
GOSS
Founded
1937
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.3M
615.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DNUT
GOSS
Price
$3.13
$2.45
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$6.22
$8.83
AVG Volume (30 Days)
2.3M
5.1M
Earning Date
02-24-2026
03-12-2026
Dividend Yield
1.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,534,272,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.19
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.76
52 Week High
$9.43
$3.87

Technical Indicators

Market Signals
Indicator
DNUT
GOSS
Relative Strength Index (RSI) 30.33 42.33
Support Level $3.03 $2.32
Resistance Level $3.31 $2.76
Average True Range (ATR) 0.15 0.23
MACD -0.02 0.01
Stochastic Oscillator 13.61 22.48

Price Performance

Historical Comparison
DNUT
GOSS

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: